Loading...
Images of Robert Tessarolo
(0 from 0 )News
Can-Fite Applies to Hold RA Phase 3 Trial for Piclidenoson in ...rheumatoidarthritisnews.com › › can-fite-files-clinical-tria...
rheumatoidarthritisnews.com
“New therapies are needed for people who face the tremendously debilitating symptoms of rheumatoid arthritis,” said Robert Tessarolo, ...
ozenoxacin cream 1% - Longwoods Publishingwww.longwoods.com › newsdetail › print
www.longwoods.com
... the Health Canada approval and look forward to making OZANEX available in Canada later this year," said Robert Tessarolo, President and CEO of Cipher.
Stockwatch
www.stockwatch.com
No Hype - just the Facts. Your complete source of news and realtime quotes from the TSX, TSX-V, CSE, Montreal, Nasdaq, NYSE, Amex and OTC Markets.
sorted by relevance / date